ATE66926T1 - Antibiotikum f-0769, verfahren zu dessen herstellung und dessen benutzung als ein das wachstum foerderndes und die futtereffizienz verstaerkendes mittel und als antitumor-mittel. - Google Patents

Antibiotikum f-0769, verfahren zu dessen herstellung und dessen benutzung als ein das wachstum foerderndes und die futtereffizienz verstaerkendes mittel und als antitumor-mittel.

Info

Publication number
ATE66926T1
ATE66926T1 AT87102981T AT87102981T ATE66926T1 AT E66926 T1 ATE66926 T1 AT E66926T1 AT 87102981 T AT87102981 T AT 87102981T AT 87102981 T AT87102981 T AT 87102981T AT E66926 T1 ATE66926 T1 AT E66926T1
Authority
AT
Austria
Prior art keywords
measured
reaction
agent
methanol
antibiotic
Prior art date
Application number
AT87102981T
Other languages
English (en)
Inventor
Hideo Sugawara
Tomonori Takashina
Nobuko Takahashi
Machiko Sugiyama
Akio Seino
Yukio Miyazaki
Original Assignee
Kaken Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharma Co Ltd filed Critical Kaken Pharma Co Ltd
Application granted granted Critical
Publication of ATE66926T1 publication Critical patent/ATE66926T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AT87102981T 1986-03-04 1987-03-03 Antibiotikum f-0769, verfahren zu dessen herstellung und dessen benutzung als ein das wachstum foerderndes und die futtereffizienz verstaerkendes mittel und als antitumor-mittel. ATE66926T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4522686 1986-03-04
EP87102981A EP0235795B1 (de) 1986-03-04 1987-03-03 Antibiotikum F-0769, Verfahren zu dessen Herstellung und dessen Benutzung als ein das Wachstum förderndes und die Futtereffizienz verstärkendes Mittel und als Antitumor-Mittel

Publications (1)

Publication Number Publication Date
ATE66926T1 true ATE66926T1 (de) 1991-09-15

Family

ID=12713349

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87102981T ATE66926T1 (de) 1986-03-04 1987-03-03 Antibiotikum f-0769, verfahren zu dessen herstellung und dessen benutzung als ein das wachstum foerderndes und die futtereffizienz verstaerkendes mittel und als antitumor-mittel.

Country Status (9)

Country Link
US (1) US4904470A (de)
EP (1) EP0235795B1 (de)
JP (1) JPH072759B2 (de)
CN (1) CN87102651A (de)
AT (1) ATE66926T1 (de)
AU (1) AU589255B2 (de)
CA (1) CA1302926C (de)
DE (1) DE3772591D1 (de)
PL (1) PL155985B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives
US5217952A (en) * 1988-02-02 1993-06-08 Fujisawa Pharmaceutical Co., Ltd. Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
US5436140A (en) * 1988-02-02 1995-07-25 Fujisawa Pharmaceutical Co., Ltd. Process for producing WS-9326A and WS-9326B
NZ229552A (en) * 1988-06-20 1992-06-25 Merrell Dow Pharma Neurokinin a antagonists
US7687646B2 (en) 2006-03-28 2010-03-30 Azad Pharmaceutical Ingredients, Ag Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof

Also Published As

Publication number Publication date
PL264409A1 (en) 1988-07-21
CN87102651A (zh) 1987-12-30
EP0235795A3 (en) 1989-03-22
AU589255B2 (en) 1989-10-05
US4904470A (en) 1990-02-27
PL155985B1 (pl) 1992-01-31
JPS6310797A (ja) 1988-01-18
EP0235795A2 (de) 1987-09-09
EP0235795B1 (de) 1991-09-04
CA1302926C (en) 1992-06-09
DE3772591D1 (de) 1991-10-10
AU6959187A (en) 1987-09-10
JPH072759B2 (ja) 1995-01-18

Similar Documents

Publication Publication Date Title
Petersen et al. An in vitro system for studying the kinetics of interchain disulfide bond formation in immunoglobulin G
Chamberlin Use of the 3, 5-dimethoxybenzyloxycarbonyl group as a photosensitive N-protecting group
Dalgliesh The relation between pyridoxin and tryptophan metabolism, studied in the rat
Patchornik et al. Reactive species mutually isolated on insoluble polymeric carriers. I. Directed monoacylation of esters
Bunnenberg et al. Inherently dissymmetric chromophores and circular dichroism
Harada et al. Determining the chirality of two aromatic chromophores and the absolute configurations of chromomycin A3 and related antibiotics
Kgzuka et al. Pigmented contact dermatitis from azo dyes: I. Cross‐sensitivity in humans
DE4137934A1 (de) Neue pentacyklische verbindungen und ihre verwendung als absorptions- oder fluoreszenzfarbstoffe
ATE66926T1 (de) Antibiotikum f-0769, verfahren zu dessen herstellung und dessen benutzung als ein das wachstum foerderndes und die futtereffizienz verstaerkendes mittel und als antitumor-mittel.
Ellestad et al. Structure and chemistry of antibiotic LL-Z1271. alpha., an antifungal carbon-17 terpene
Boothe et al. 6-Deoxytetracyclines. I. Chemical modification by electrophilic substitution
Harada Absolute configuration of (+)-trans-abscisic acid as determined by a quantitative application of the exciton chirality method
Hart et al. A new synthesis of defucogilvocarcin M
ES2163038T3 (es) Procedimiento para la preparacion de clavulanato de potasio.
Lai et al. High-performance thin-layer chromatography of free porphyrins for diagnosis of porphyria
Vever-Bizet et al. The purification of haematoporphyrin IX and its acetylated derivatives
KR850004497A (ko) 항생물질 l17054를 제조하는 방법
US4841038A (en) Method for preparing coenzyme a esters of all-trans- and 13-cis retinoic acids
Hamada et al. Molecular-recognition and sensory system of γ-cyclodextrin capped by sodium anthranilate
Johnson et al. Persistence of skin color and fluorescence after treatment with dihydroxyacetone
Nakano Studies on trichomycin. VI
Manelli Cephalexin
Dickinson et al. Levamisole: its stability in aqueous solutions at elevated temperatures. Part I. Isolation and identification of decomposition products formed in aqueous solutions of levamisole stored under nitrogen and oxygen at 100° C
Tominaga Mechanism of the Ninhydrin Reaction on a Filter Paper
KR890002408A (ko) 항생물질 f-0769, 그의 제조방법 및 그의 성장가속 및 사료효율 증가제 및 항종양제로서의 용도

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties